ABMD DMA
As of date:2/25/2020
ABMD stock price:158.80
ABMD 50 DMA:176.83
ABMD 200 DMA:207.04
ABMD MACD (200-50):30.21

Also see:
ABMD Market Cap History
ABMD Shares Outstanding History
ABMD YTD Return
ABMD RSI
ABMD MACD
ABMD Technical Analysis

SCS Crosses Below Key Moving Average Level
48 minutes ago


GES Crosses Below Key Moving Average Level
58 minutes ago


Jones Lang LaSalle (JLL) Shares Cross Below 200 DMA
58 minutes ago


Notable Two Hundred Day Moving Average Cross - URI
58 minutes ago


SRT Makes Notable Cross Below Critical Moving Average
58 minutes ago


EL Crosses Below Key Moving Average Level
59 minutes ago


THG Makes Notable Cross Below Critical Moving Average
1 hour, 1 minute ago


ITT Shares Cross Below 200 DMA
1 hour, 1 minute ago


SR Crosses Below Key Moving Average Level
1 hour, 4 minutes ago


CMO Crosses Below Key Moving Average Level
1 hour, 4 minutes ago


KeyCorp Breaks Below 200-Day Moving Average - Notable for KEY
1 hour, 5 minutes ago


Notable Two Hundred Day Moving Average Cross - WAB
1 hour, 6 minutes ago


WSM Makes Notable Cross Below Critical Moving Average
1 hour, 6 minutes ago


TFC Crosses Below Key Moving Average Level
1 hour, 6 minutes ago


IEX Crosses Below Key Moving Average Level
1 hour, 6 minutes ago


More Technical Analysis News

ABMD DMAABMD MACD
ABIOMED is a provider of temporary mechanical circulatory support devices, and it provides a continuum of care to heart failure patients. Co.'s products include: Impella 2.5®, which is a percutaneous micro heart pump with an integrated motor and sensors; which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, which is a percutaneous catheter-based axial flow pump that is designed to allow more than four liters of flow per minute.

When researching a stock like ABIOMED, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ABMD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ABMD stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the ABMD 200 day moving average ("ABMD 200 DMA"), while one of the most popular "shorter look-backs" is the ABMD 50 day moving average ("ABMD 50 DMA"). A chart showing both of these popular moving averages is shown on this page for ABIOMED.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABMD:
ABMD SEC Filing Email Alerts ServiceExternal link
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ABIOMED (ABMD) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

ABT DMA
AGN DMA
ALGN DMA
ALXN DMA
AMGN DMA
BAX DMA
BDX DMA
BIIB DMA
BMY DMA
BSX DMA
More Healthcare companies »

 

ABMD DMA | www.StockDMA.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.